Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)
2016 · Reproductive Biology and Endocrinology · 88 citations
https://doi.org/10.1186/s12958-015-0135-8